论文部分内容阅读
目的:观察疏血通注射液治疗高血压性脑出血的疗效。方法:将73例高血压性脑出血患者随机分为治疗组35例、对照组38例。观察两组的临床疗效、神经功能缺损程度评分以及颅内血肿容积的变化。结果:治疗后治疗组显效率为62.86%,有效率为91.43%;对照组分别为39.47%和81.58%。两组显效率比较,差异有显著性意义(P<0.05),但两组有效率比较,差异无统计学意义(P>0.05)。治疗后两组神经功能缺损评分均降低,与治疗前比较,差异均有非常显著性意义(P<0.01),且治疗组评分低于对照组(P<0.05)。治疗后两组血肿容积均明显减小,与治疗前比较,差异均有非常显著性意义(P<0.01),且治疗组减少较对照组更为显著(P<0.05)。结论:疏血通注射液可提高高血压性脑出血临床疗效。
Objective: To observe the curative effect of Shuxuetong injection on hypertensive intracerebral hemorrhage. Methods: Seventy-three patients with hypertensive intracerebral hemorrhage were randomly divided into treatment group (35 cases) and control group (38 cases). The clinical efficacy, the score of neurological deficits and the changes of intracranial hematoma volume were observed. Results: After treatment, the effective rate was 62.86% and the effective rate was 91.43% in the treatment group and 39.47% and 81.58% in the control group respectively. Significant difference between the two groups was significant (P <0.05), but there was no significant difference between the two groups (P> 0.05). After treatment, the score of neurological deficit in both groups decreased, with significant difference (P <0.01) compared with those before treatment, and the score of the treatment group was lower than that of the control group (P <0.05). After treatment, the hematoma volume of both groups were significantly reduced, compared with the pre-treatment, the difference was significant (P <0.01), and the treatment group decreased more significantly than the control group (P <0.05). Conclusion: Shuxuetong injection can improve the clinical efficacy of hypertensive intracerebral hemorrhage.